Search Results
May 08, 2026, 09:00 ET Co-Diagnostics Joint Venture CoMira Finalizes Lease Agreement for Manufacturing Facility in Saudi Arabia's Sudair Industrial City
diagnostics technologies. The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform (subject to
More news about: Co-Diagnostics
May 08, 2026, 08:05 ET INOVIO to Participate in Upcoming Scientific Conferences
biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting
More news about: INOVIO Pharmaceuticals, Inc.
May 08, 2026, 06:40 ET The sNDA for Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First‑Line Treatment for PD-L1-positive NSCLC Accepted for Review by NMPA
antibodies, which is then endocytosed by tumor cells and releases the payload KL610023 intracellularly. KL610023, as a topoisomerase I inhibitor, induces DNA damage to tumor cells, which in turn leads to cell-cycle arrest and apoptosis. In addition, it also releases KL610023 in the tumor microenvironment.
More news about: Kelun-Biotech
May 07, 2026, 16:55 ET MDA SPACE ANNOUNCES 2026 ANNUAL GENERAL MEETING RESULTS
vision into an achievable mission – bringing to bear a one-of-a-kind mix of experience, engineering excellence and wide-eyed wonder that's been in our DNA since day one. For those who dream big and push boundaries on the ground and in the stars to change the world for the better, we'll take you there. For
More news about: MDA Space
May 07, 2026, 16:05 ET Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous Lab
businessBOSTON, May 7, 2026 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo") today announced its results for the first quarter of 2026 that ended March 31, 2026. The update, including a webcast slide presentation with
More news about: Ginkgo Bioworks
May 07, 2026, 12:00 ET The Ritz-Carlton Redefines Race Weekend Luxury with the U.S. SailGP Team in New York City
sponsors the U.S. SailGP Team, uniting the precision of high-performance sailing with the excellence of luxury hospitality. With innovation embedded in its DNA, The Ritz-Carlton continues to push beyond traditional boundaries—engaging audiences through pioneering brand extensions such as The Ritz-Carlton Yacht
More news about: Marriott International, Inc.
May 07, 2026, 11:09 ET Marqo Introduces Commerce Superintelligence with the Launch of Sibbi: The Intelligence Layer for the Next Era of Product Discovery
language in a single query. A shopper can upload an image and refine the search with text, such as "find this style in black." By understanding the visual DNA of a product, Sibbi resolves aesthetic intent that text-only systems cannot.Post-Purchase Revenue Continuity: Sibbi transforms logistics
More news about: Marqo
May 07, 2026, 09:00 ET GI Partners Completes Acquisition of the CDMO and Cell Solutions Businesses from Charles River Laboratories and forms Rose BioSolutions
to deliver end-to-end advanced therapy solutions for clients, providing CDMO's full-service development and manufacturing capabilities across plasmid DNA, viral vector, and cell therapy capabilities, as well as Cell Solutions' ability to deliver the cellular materials that research and advanced therapies
More news about: GI Partners
May 07, 2026, 09:00 ET The National Safety Council Honors UL Solutions with 2026 Robert W. Campbell Award
it's a powerful affirmation of our mission of working for a safer world," said Jennifer Scanlon, president and CEO of UL Solutions. "Safety is in our DNA, and it's embedded in our culture. From the way we operate to the solutions we deliver, advancing safety has defined UL Solutions for more than 130 years."UL
More news about: National Safety Council
May 07, 2026, 09:00 ET FÜSSE MIT EINEM HAUCH FARBE FEIERN: BIRKENSTOCK PRÄSENTIERT NEUE NAGELLACK-KOLLEKTION
7. Mai 2026 /PRNewswire/ -- Füßen die Aufmerksamkeit schenken, die sie verdienen – dieser Anspruch ist fest in BIRKENSTOCKs Marken-DNA verankert und zahlt auf den Purpose des Naturgewollten Gehens ein, der vom anatomisch geformten Fußbett verkörpert wird. Im Einklang mit diesem ganzheitlichen
More news about: BIRKENSTOCK Group
May 07, 2026, 09:00 ET CELEBRATING FEET WITH A TOUCH OF COLOR: BIRKENSTOCK INTRODUCES NAIL POLISH COLLECTION
Germany, May 7, 2026 /PRNewswire/ -- Giving feet the attention they deserve is deeply rooted in BIRKENSTOCK's DNA and underscores the purpose of "walking as nature intended," a principle embodied in the iconic BIRKENSTOCK footbed. In keeping with its holistic philosophy,
More news about: BIRKENSTOCK Group
May 07, 2026, 09:00 ET CELEBRATING FEET WITH A TOUCH OF COLOR: BIRKENSTOCK INTRODUCES NAIL POLISH COLLECTION
Germany, May 7, 2026 /PRNewswire/ -- Giving feet the attention they deserve is deeply rooted in BIRKENSTOCK's DNA and underscores the purpose of "walking as nature intended," a principle embodied in the iconic BIRKENSTOCK footbed. In keeping with its holistic philosophy,
More news about: BIRKENSTOCK Group
May 07, 2026, 08:00 ET New findings suggest 5-MTHF is a viable alternative to folic acid during second and third trimester, supporting folate status while reducing excess folic acid in circulation
randomized, double-blind, controlled clinical trial on 62 second and third trimester pregnant women.Folate helps the body produce and maintain DNA, which is essential for the growth and development of the fetus. While folic acid is a commonly used form of folate in supplements and fortified in foods,
More news about: Ritual
May 07, 2026, 06:14 ET PHERGain and PHERGain-2 advance therapeutic de-escalation in early HER2-positive breast cancer in selected patients
and its associated toxicities.In addition, the company presented a translational analysis of the PHERGain study showing that circulating tumor DNA detected through liquid biopsy represents a precise, rapid, and non-invasive tool with the potential to identify patients who will remain disease-free
More news about: MEDSIR
May 07, 2026, 05:45 ET MDA SPACE REPORTS FIRST QUARTER 2026 RESULTS
vision into an achievable mission – bringing to bear a one-of- a-kind mix of experience, engineering excellence and wide-eyed wonder that's been in our DNA since day one. For those who dream big and push boundaries on the ground and in the stars to change the world for the better, we'll take you there. For
More news about: MDA Space
May 06, 2026, 16:58 ET TerraPower Isotopes Breaks Ground on World's Largest Actinium-225 Manufacturing Facility in Philadelphia
said Andrew Chused, chief investment officer of HRP Group. "At HRP, unabashed optimism and the relentless pursuit of what's possible are in our DNA, and in TerraPower Isotopes we've found an innovator who shares that commitment to breaking boundaries and solving the unsolvable. Their decision to
More news about: TerraPower Isotopes
May 06, 2026, 09:29 ET Partner Therapeutics Announces Receipt of FDA Commissioner's National Priority Voucher for BIZENGRI® (Zenocutuzumab-zbco) in NRG1 Fusion-Positive Cholangiocarcinoma
and NRG1 fusion interactions with HER3, resulting in the suppression of these pathways. Comprehensive molecular testing, notably the combination of tissue-based DNA and RNA next generation sequencing, is essential to identify rare and actionable gene fusions like NRG1. About BIZENGRI (zenocutuzumab-zbco) INDICATIONS BIZENGRI
More news about: Partner Therapeutics, Inc.
May 06, 2026, 09:20 ET Landmark CLiMB Study Demonstrates Superior Sensitivity of HelioLiver™, a Multi-Analyte Blood Test, Over Ultrasound for Early Detection of Hepatocellular Carcinoma
form of liver cancer. HelioLiver™ is designed to fit into routine liver cancer surveillance schedules with a simple blood draw. By combining cell-free DNA methylation patterns, protein biomarkers, and patient demographics using a proprietary AI algorithm, HelioLiver™ aims to provide an additional source
More news about: Helio Genomics
May 06, 2026, 08:17 ET Interlink Commerce Approved as Official Walmart Marketplace Solution Provider, Signaling a New Era for Mid-Market Sellers
for years.Interlink Commerce sees that gap as the most significant opportunity in marketplace services today. By pairing deep data-integration DNA with purpose-built Walmart connectivity, the company intends to become the operational backbone that sellers trust to keep their listings, inventory,
More news about: Interlink Commerce, INC
May 06, 2026, 07:00 ET (E,E)-bisantrene Discovered to Function via Silencing of c-MYC Expression
G-quadruplex (G4) DNA and RNA structures, key regulatory elements involved in controlling oncogene expression.At the American Association for Cancer Research (AACR) Annual Meeting 2026, Racura presented new preclinical data demonstrating that (E,E)-bisantrene directly binds and stabilizes G4 DNA structures
More news about: Racura Oncology
May 06, 2026, 03:00 ET Ribbon Bio Launches Cell-Free MiroSynth DNA and New In-Lab Cell-Free DNA Production Kit
BioRibbon Bio is a cell-free DNA developer transforming access to high-fidelity DNA molecules. By producing DNA independent of bacterial-mediated processes, Ribbon sidesteps many of the limitations inherent to traditional plasmid-based approaches, delivering purer DNA, faster production timelines, and
More news about: Ribbon Bio
May 06, 2026, 02:00 ET Campari volta a Cannes para celebrar os momentos que definem o cinema
cinematográfica, criatividade e influência cultural, e a Campari tem orgulho de retornar mais uma vez como parceira oficial. O cinema sempre fez parte do nosso DNA, e Cannes reúne cineastas, talentos e líderes do setor em um palco verdadeiramente global. Como um ótimo cinema, nosso aperitivo desperta os sentidos
More news about: Campari
May 06, 2026, 02:00 ET CAMPARI RETURNS TO CANNES TO CELEBRATE THE MOMENTS THAT DEFINE CINEMA
cinematic passion, creativity and cultural influence, and Campari is proud to return once again as an Official Partner. Cinema has always been part of our DNA, and Cannes brings filmmakers, talent and industry leaders together on a truly global stage. Like great cinema, our aperitif awakens the senses and leaves
More news about: Campari
May 06, 2026, 02:00 ET CAMPARI KEERT TERUG NAAR CANNES OM ICONISCHE FILMMOMENTEN TE VIEREN
creativiteit en culturele invloed, en Campari is er trots op opnieuw als officiële partner terug te keren. Cinema heeft altijd al deel uitgemaakt van ons DNA en Cannes brengt filmmakers, talenten en brancheleiders samen op een waar wereldwijd podium. Net als geweldige cinema maakt ons aperitief de zintuigen
More news about: Campari
May 06, 2026, 02:00 ET CAMPARI TORNA A CANNES 2026 PER CELEBRARE I MOMENTI CHE DEFINISCONO IL CINEMA
creatività e influenza culturale, e Campari è orgogliosa di tornare ancora una volta come Partner Ufficiale. Il cinema è sempre stato parte del nostro DNA, e Cannes riunisce registi, talenti e leader del settore su un palcoscenico davvero globale. Come il grande cinema, il nostro aperitivo risveglia i sensi
More news about: Campari